Patterson-UTI Energy, Inc. PTEN ← Back to all reports

Patterson-UTI Energy, Inc.

PTEN · Energy
B ★★★ Hold
Aug 20, 2026 · Score 76 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $12.13
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $10.50 ($10.00–$11.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $13.41
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+10.5%

Type A - Patterson-UTI Energy, Inc. (PTEN) 20260820 Stock Analysis

📅 Patterson-UTI Key Upcoming Events

🏢 Step 1: Patterson-UTI Company Overview & Business Model

Q1-A1. What is Patterson-UTI?

Q1-A2. How Does Patterson-UTI Make Money?

Q1-A3. Patterson-UTI’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Patterson-UTI’s Competitors?

Q1-A5. Patterson-UTI Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Patterson-UTI’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Patterson-UTI Have a Durable Economic Moat?

Q2-A2. Is Patterson-UTI’s Growth Sustainable?

Q2-A3. How Does Patterson-UTI Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Patterson-UTI Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Patterson-UTI? (Margins & ROIC)

Q3-A3. What Drives Patterson-UTI’s Returns? (ROIC Breakdown)

Q3-A4. Are Patterson-UTI’s Earnings High Quality?

Q3-A5. Is Patterson-UTI’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Patterson-UTI Forensic Accounting & Dilution Review

Q4-A1. Does Patterson-UTI Have Accounting Red Flags?

Q4-A2. Is Patterson-UTI Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Patterson-UTI’s Cash Flow?

Q4-A4. Is Patterson-UTI Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Patterson-UTI Management & Shareholder Alignment

Q5-A1. Can You Trust Patterson-UTI’s Management? (Guidance Track Record)

Q5-A2. What Are Patterson-UTI Insiders Doing?

Q5-A3. Is Patterson-UTI’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Patterson-UTI Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Patterson-UTI Guidance

Q6-A2. What Is Patterson-UTI’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Patterson-UTI Catalysts & Price Triggers

Q7-A1. What Could Move Patterson-UTI Stock? (Top 3 Catalysts)

Q7-A2. Patterson-UTI’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Patterson-UTI Fairly Valued? Valuation Analysis

Q8-A1. Patterson-UTI’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Patterson-UTI vs Peers: Valuation Comparison

Q8-A3. Is Patterson-UTI Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Patterson-UTI? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Patterson-UTI? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Patterson-UTI’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Patterson-UTI? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Patterson-UTI?

Q9-A2. How Sensitive Is Patterson-UTI to the Economy?

Q9-A3. Patterson-UTI Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Patterson-UTI Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Patterson-UTI? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Patterson-UTI’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Patterson-UTI’s Heavy Dependence on the Commoditized U.S. Shale Market Its Biggest Weakness?

Q2: Can Patterson-UTI’s 6.3x EV/EBITDA Multiple Be Justified by the Upcoming LNG Export Supercycle?

Q3: Did the $3.5 Billion NexTier Oilfield Solutions Merger Destroy Long-Term Shareholder Value Through Massive Equity Dilution?

Q4: How Does Patterson-UTI’s $1.29 Billion Total Debt Load Threaten Its Reinvestment and Dividend Capabilities in a High-Interest Rate Environment?

Q5: Does the Sustained Wave of Insider Selling by CEO Andy Hendricks and Other Executives Constitute a Fatal Psychological Red Flag?

Q6: Will Patterson-UTI’s Strategic Exit From Colombian Contract Drilling Permanently Damage Its International Growth Trajectory?

Q7: Can Patterson-UTI’s High-Margin Drilling Products Segment Truly Outgrow the Cyclical Constraints of U.S. Land Drilling?

Q8: Does Patterson-UTI’s Proprietary Cortex Automation Platform Provide Genuine Switching Costs in a Traditionally Cutthroat Pricing Market?

Q9: Is Patterson-UTI’s Aggressive Mandate to Return 50% of Adjusted Free Cash Flow Actually Sustainable Through a Macroeconomic Recession?

Q10: Does the Severe Structural Disconnect Between Patterson-UTI’s Operating Cash Flow and GAAP Net Income Hide Imminent Insolvency Risks?